Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Feng Wang, Chen Xu Zhou, Zhi Zheng, Du Juan Li, Wen Li & Yun Zhou. (2023) Metformin reduces myogenic contracture and myofibrosis induced by rat knee joint immobilization via AMPK-mediated inhibition of TGF-β1/Smad signaling pathway. Connective Tissue Research 64:1, pages 26-39.
Read now
Read now
Lei Zhang, Xiaochun Zhang, Lihua Guan, Daxin Zhou & Junbo Ge. (2023) AMPK/mTOR-mediated therapeutic effect of metformin on myocardial ischaemia reperfusion injury in diabetic rat. Acta Cardiologica 78:1, pages 64-71.
Read now
Read now
Articles from other publishers (28)
Ji Zhang, Yuanyuan Zhao & Nianqiao Gong. (2023) XBP1 Modulates the Aging Cardiorenal System by Regulating Oxidative Stress. Antioxidants 12:11, pages 1933.
Crossref
Crossref
Yuan Gui, Zachary Palanza, Haiyan Fu & Dong Zhou. (2023) Acute kidney injury in diabetes mellitus: Epidemiology, diagnostic, and therapeutic concepts. The FASEB Journal 37:4.
Crossref
Crossref
Mahshid Deldar Abad Paskeh, Ava Asadi, Sepideh Mirzaei, Mehrdad Hashemi, Maliheh Entezari, Rasoul Raesi, Kiavash Hushmandi, Ali Zarrabi, Yavuz Nuri Ertas, Amir Reza Aref, Saeed Samarghandian, Russel J. Reiter & Jun Ren. (2022) Targeting AMPK signaling in ischemic/reperfusion injury: From molecular mechanism to pharmacological interventions. Cellular Signalling 94, pages 110323.
Crossref
Crossref
Cody A. Rutledge, Brett A. Kaufman, Cameron Dezfulian & Jonathan Elmer. (2022) Metformin protects against cardiac and renal damage in diabetic cardiac arrest patients. Resuscitation 174, pages 42-46.
Crossref
Crossref
Mengjia Dou, Chennan Lu & Wei Rao. (2022) Bioinspired materials and technology for advanced cryopreservation. Trends in Biotechnology 40:1, pages 93-106.
Crossref
Crossref
Xiaowei Bao, Xiandong Liu, Na Liu, Shougang Zhuang, Qian Yang, Huijuan Ren, Dongyang Zhao, Jianwen Bai, Xiaohui Zhou & Lunxian Tang. (2021) Inhibition of EZH2 prevents acute respiratory distress syndrome (ARDS)-associated pulmonary fibrosis by regulating the macrophage polarization phenotype. Respiratory Research 22:1.
Crossref
Crossref
Anni Song, Chun Zhang & Xianfang Meng. (2021) Mechanism and application of metformin in kidney diseases: An update. Biomedicine & Pharmacotherapy 138, pages 111454.
Crossref
Crossref
Zeyuan Song, Tao Wu, Jinpeng Sun, Haoran Wang, Feng Hua, Yap San Min Nicolas, Rupesh KC, Kun Chen, Zhen Jin, Jun Liu & Mingshun Zhang. (2021) Metformin attenuates post‐epidural fibrosis by inhibiting the TGF‐β1/Smad3 and HMGB1/TLR4 signaling pathways. Journal of Cellular and Molecular Medicine 25:7, pages 3272-3283.
Crossref
Crossref
Mengkui Sun, Wei Zhou, Fei Yao, Jianming Song, Yanan Xu, Zhimei Deng, Hongwang Diao & Shoulin Li. (2021) MicroRNA-302b mitigates renal fibrosis via inhibiting TGF-β/Smad pathway activation. Brazilian Journal of Medical and Biological Research 54:3.
Crossref
Crossref
Yubo Wang, Caiyu Lin, Rui Han, Conghua Lu, Li Li, Chen Hu, Mingxia Feng, Hengyi Chen & Yong He. (2020) Metformin attenuates TGF-β1-induced pulmonary fibrosis through inhibition of transglutaminase 2 and subsequent TGF-β pathways. 3 Biotech 10:6.
Crossref
Crossref
Mengnan Lu, Huangtao Chen, Fayi Nie, Xinyi Wei, Zhiwei Tao & Jie Ma. (2020) The potential role of metformin in the treatment of Parkinson's disease. Journal of Bio-X Research 3:1, pages 27-35.
Crossref
Crossref
Curtis W. McCloskey, David P. Cook, Brendan S. Kelly, Feryel Azzi, Christian H. Allen, Amanda Forsyth, Jeremy Upham, Katey J. Rayner, Douglas A. Gray, Robert W. Boyd, Sangeeta Murugkar, Bryan Lo, Dominique Trudel, Mary K. Senterman & Barbara C. Vanderhyden. (2020) Metformin Abrogates Age-Associated Ovarian Fibrosis. Clinical Cancer Research 26:3, pages 632-642.
Crossref
Crossref
E. Soo, A. Welch, C. Marsh & DB. McKay. (2020) Molecular strategies used by hibernators: Potential therapeutic directions for ischemia reperfusion injury and preservation of human donor organs. Transplantation Reviews 34:1, pages 100512.
Crossref
Crossref
Teresa Salvatore, Pia Clara Pafundi, Raffaele Marfella, Celestino Sardu, Luca Rinaldi, Lucio Monaco, Carmen Ricozzi, Simona Imbriani, Riccardo Nevola, Luigi Elio Adinolfi & Ferdinando Carlo Sasso. (2019) Metformin lactic acidosis: Should we still be afraid?. Diabetes Research and Clinical Practice 157, pages 107879.
Crossref
Crossref
Ming‐Chia Lee, Chih‐Hsin Lee, Lih‐Yu Chang, Chia‐Hao Chang, Jun‐Fu Zhang, Meng‐Rui Lee, Jann‐Yuan Wang & Shih‐Ming Chen. (2019) Association of Metformin Use With End‐Stage Renal Disease in Patients With Type 2 Diabetes Mellitus: A Nationwide Cohort Study Under the Pay‐for‐Performance Program. The Journal of Clinical Pharmacology 59:11, pages 1443-1452.
Crossref
Crossref
Can-Xiang Lin, Yan Li, Shi Liang, Jun Tao, Li-Sui Zhang, Yang-Fan Su, Yun-Xi Huang, Zong-Kai Zhao, Shan-Ying Liu & Jun-Meng Zheng. (2019) Metformin Attenuates Cyclosporine A-induced Renal Fibrosis in Rats. Transplantation 103:10, pages e285-e296.
Crossref
Crossref
Diefei Liang, Zijiao Song, Weiwen Liang, Yan Li & Shanying Liu. (2019) Metformin inhibits TGF‐beta 1‐induced MCP‐1 expression through BAMBI‐mediated suppression of MEK/ERK1/2 signalling. Nephrology 24:4, pages 481-488.
Crossref
Crossref
Raphaëlle Corremans, Benjamin A. Vervaet, Patrick C. D’Haese, Ellen Neven & Anja Verhulst. (2018) Metformin: A Candidate Drug for Renal Diseases. International Journal of Molecular Sciences 20:1, pages 42.
Crossref
Crossref
Yu-Shen Huang, Shwu-Huey Wang, Shih-Ming Chen & Jen-Ai Lee. (2018) Metabolic profiling of metformin treatment for low-level Pb-induced nephrotoxicity in rat urine. Scientific Reports 8:1.
Crossref
Crossref
Maria Fernanda Ribeiro Cury, Estéfany Queiroz Olivares, Renata Correia Garcias, Giovana Queda Toledo, Natassia Alberici Anselmo, Leticia Colombo Paskakulis, Fernanda Fortuci Resende Botelho, Natiele Zanardo Carvalho, Analice Andreoli da Silva, Camila Agren & Carla Patrícia Carlos. (2018) Inflammation and kidney injury attenuated by prior intake of Brazil nuts in the process of ischemia and reperfusion. Brazilian Journal of Nephrology 40:4, pages 312-318.
Crossref
Crossref
Cemile Dayangan Sayan, Gokhan Karaca, Zehra Sema Ozkan, Ozlem B. Tulmac, Aslı Ceylan Isik, Tuba Devrim, Gülcin Aydin & Ilkin Yeral. (2018) What is the protective effect of metformin on rat ovary against ischemia-reperfusion injury?. Journal of Obstetrics and Gynaecology Research 44:2, pages 278-285.
Crossref
Crossref
Marc E. De Broe, Farshad Kajbaf & Jean-Daniel Lalau. (2018) Renoprotective Effects of Metformin. Nephron 138:4, pages 261-274.
Crossref
Crossref
Richard E. Kast, Nicolas Skuli, Georg Karpel-Massler, Guido Frosina, Timothy Ryken & Marc-Eric Halatsch. (2017) Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen. Oncotarget 8:37, pages 60727-60749.
Crossref
Crossref
Shuai Jiang, Tian Li, Zhi Yang, Wei Yi, Shouyin Di, Yang Sun, Dongjin Wang & Yang Yang. (2017) AMPK orchestrates an elaborate cascade protecting tissue from fibrosis and aging. Ageing Research Reviews 38, pages 18-27.
Crossref
Crossref
E Lioudaki, M Whyte, ES Androulakis, KG Stylianou, EK Daphnis & ES Ganotakis. (2017) Renal Effects of SGLT‐2 Inhibitors and Other Anti‐diabetic Drugs: Clinical Relevance and Potential Risks. Clinical Pharmacology & Therapeutics 102:3, pages 470-480.
Crossref
Crossref
Yenan Feng, Shuaixing Wang, Youyi Zhang & Han Xiao. (2017) Metformin attenuates renal fibrosis in both AMPKα2-dependent and independent manners. Clinical and Experimental Pharmacology and Physiology 44:6, pages 648-655.
Crossref
Crossref
Lijun Tao, Juan Cao, Wencheng Wei, Haifeng Xie, Mian Zhang & Chaofeng Zhang. (2017) Protective role of rhapontin in experimental pulmonary fibrosis in vitro and in vivo. International Immunopharmacology 47, pages 38-46.
Crossref
Crossref
Kerui Fan, Kejia Wu, Ling Lin, Pu Ge, Jie Dai, Xiaojiao He, Kai Hu & Li Zhang. (2017) Metformin mitigates carbon tetrachloride-induced TGF-?1/Smad3 signaling and liver fibrosis in mice. Biomedicine & Pharmacotherapy 90, pages 421-426.
Crossref
Crossref